… strategies, and novel systemic therapies including chemotherapy and immunotherapies
are gradually changing the treatment paradigm and prognosis of this recalcitrant cancer. …

… Gallbladder cancer (GC) is a relatively rare but highly lethal neoplasm. We review the …
T3 and T4 are mostly systemic disease, because, for example, accidental intraoperative …

… mortality from gallbladder cancer. Vague symptoms often delay the diagnosis of gallbladder
cancer, … Citation27,Citation28 In a recent systematic review of 340 patients with gallbladder …

… Gallbladder cancer is one of the most lethal carcinomas and continues to pose many
challenges for surgeons. Identifiable risk factors for carcinoma of the gallbladder … A systematic …

… cancers; hence, it is not clear which are driving mutations unique to gallbladder cancer.
Certain mutations are associated with other cancer risk factors; for instance, gallbladder cancer …

… This review evaluated the surgical outcomes of T1 GB cancer. The evidence is of low quality,
because it was obtained from the reviewed articles, and most studies were case series. No …

… A systematic review of the published medical literature using PubMed and Medline was …
Manuscripts focusing on gallbladder cancer were included in this review, while those dedicated …

… This health technology assessment has focussed on surgical approaches in gallbladder
cancer. Guidelines for the treatment of gallbladder cancer are difficult to state as our knowledge …

… Notably, although gallbladder cancer usually presents in … gallbladder cancers are now
detected as incidental findings after cholecystectomy 14 , 15 . The incidence of gallbladder cancer …

… The number of patients eligible for second-line chemotherapy in this systematic review was
higher than previously reported for other BTCs (44 % vs 25 %), which suggests that patients …